Rothschild Investment LLC’s ARK Genomic Revolution ETF ARKG Stock Holding History

Rothschild Investment LLC’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$608K	Hold	14,450	–	–	0.02%	541
2026 Q1	$382K	Hold	14,450	–	–	0.02%	480
2025 Q4	$419K	Hold	14,450	–	–	0.02%	407
2025 Q3	$401K	Hold	14,450	–	–	0.02%	402
2025 Q2	$352K	Hold	14,450	–	–	0.02%	400
2025 Q1	$300K	Sell	14,450 -700	-5%	-$17.6K	0.02%	417
2024 Q4	$357K	Buy	15,150 +2,000	+15%	+$49.2K	0.02%	398
2024 Q3	$337K	Buy	13,150 +2,000	+18%	+$50.9K	0.02%	412
2024 Q2	$262K	Buy	11,150 +10,450	+1,493%	+$264K	0.02%	441
2024 Q1	$20.1K	Buy	+700	New	+$21.1K	﹤0.01%	922
2023 Q3	–	Sell	-63,095	Closed	-$2.15M	–	481
2023 Q2	$2.15M	Sell	63,095 -18,175	-22%	-$571K	0.18%	123
2023 Q1	$2.44M	Sell	81,270 -6,775	-8%	-$210K	0.21%	113
2022 Q4	$2.49M	Sell	88,045 -1,125	-1%	-$35.7K	0.23%	106
2022 Q3	$2.93M	Buy	89,170 +1,175	+1%	+$43.1K	0.29%	93
2022 Q2	$2.77M	Sell	87,995 -7,525	-8%	-$263K	0.26%	98
2022 Q1	$4.39M	Buy	+95,520	New	+$4.55M	0.34%	83

Other funds holding ARKG

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

MFPI

Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM

CIC

Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Rothschild Investment LLC's ARKG Position: Q2 2026 in Review

Rothschild Investment LLC held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 14,450 shares worth $608K. The position accounts for 0.02% of the portfolio, ranked #541.

Rothschild Investment LLC first reported a position in ARKG in Q1 2022 and has held it in 16 quarters since. The position peaked at $4.39M in Q1 2022. 157 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Rothschild Investment LLC held 14,450 shares of ARK Genomic Revolution ETF worth $608K as of Q2 2026.
Rothschild Investment LLC left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up 0.02% of Rothschild Investment LLC's portfolio in Q2 2026, its #541 holding.
Rothschild Investment LLC first reported a position in ARK Genomic Revolution ETF in Q1 2022 and has held it in 16 quarters since.
Rothschild Investment LLC's ARK Genomic Revolution ETF position peaked at $4.39M in Q1 2022.
157 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.